Cancer genomes reveal risks of sun and smoke : Nature News http://www.nature.com/news/2009/091216/full/news.2009.1143.

html

Published online 16 December 2009 | Nature | doi:10.1038/news.2009.1143

News

Cancer genomes reveal risks of sun and smoke

Sequencing of skin and lung cancers show that many mutations could be prevented.

Brendan Borrell

Researchers have completed the genetic sequences of two types of cancer — skin cancer and
small-cell lung cancer — revealing that the genomes bear the hallmarks of their respective
carcinogens: sun and smoke. Worldwide, the two diseases kill a total of nearly 250,000 people each
year, despite the fact that they are largely preventable.

Tumours develop when a normal cell's DNA is damaged, allowing that cell to proliferate unchecked.
By sequencing and cataloguing all the mutations in a single tumour type from multiple individuals,
scientists aim to identify the genes that are most susceptible to damage, to understand the processes
underlying DNA repair, and to develop drugs that counteract certain types of damage.

Scientists from the Cancer Genome Project at the Wellcome Trust Sanger Institute in Hinxton, near
Sun and smoke leave their fingerprints
Cambridge, UK, and their collaborators at partner institutions describe the genetic sequences of cell on cancer genomes.
lines derived from patients with small-cell lung cancer1 or malignant melanoma2. The studies are
MOREDUN ANIMAL HEALTH LTD /
published online today in Nature. SCIENCE PHOTO LIBRARY

These papers mark the completion of the fourth and fifth cancer-cell
“Every pack of
cigarettes is like a genomes to be sequenced, and come just one year after a team from Washington University School of Medicine in
game of Russian St Louis published the first cancer genome, from a patient with leukaemia3. The breast-cancer genome was
roulette.” published by a Canadian-led consortium in October this year4, and dozens more sequences are expected to come
out of The Cancer Genome Atlas Program of the US National Cancer Institute in Bethesda, Maryland — a project
Peter Campbell that is slated to receive US$275 million over the next two years from the National Institutes of Health.
Wellcome Trust
Sanger Institute, "We are in the middle of an explosive development in cancer-genome sequencing," says Matthew Meyerson, a
Hinxton
cancer-genomics expert at the Dana-Farber Cancer Institute in Boston, Massachusetts, who was not involved in
the research. "Whole-genome sequencing is the wave of the future for both cancer-gene discovery and, eventually,
for cancer diagnosis."

One cigarette, 15 mutations

Peter Campbell, a haemotologist and cancer-genomics expert at the Sanger Institute who worked on the latest studies, says that the number
of genetic mutations they identified — 33,345 for melanoma and 22,910 for lung cancer — was remarkable. The mutations were not
distributed evenly throughout the genome — many were present outside of gene-coding regions, suggesting that cells had repaired damaged
DNA in those key regions.

Campbell says that the findings help to answer lingering questions about whether carcinogens cause most mutations directly, or if cancer
itself contributes to the mutations by disrupting the function of DNA-repair mechanisms. The team found that most mutations were
single-base DNA substitutions that could be traced to the carcinogenic effects of chemicals in tobacco smoke (in the case of the small-cell lung
cancer genome) or ultraviolet light (in the melanoma genome), supporting the idea that these two cancers are largely preventable. The team
estimates that every cigarette smoked results in 15 mutations. "Every pack of cigarettes is like a game of Russian roulette," Campbell says.
"Most of those mutations will land where nothing happens in the genome and won't do major damage, but every once in a while they'll hit a
cancer gene."

The lung-cancer study also identified one recurrent mutation — a duplication of the chromatin- ADVERTISEMENT

remodelling gene CHD7, which regulates the activity of other genes. The team had already
identified the existence of this mutation in 2008, but the current study1 confirms its presence in
three independent cell lines. Such recurrent mutations could point to key cancer genes that may
be useful drug targets.

Some scientists, however, are more circumspect about the benefits of cancer-genome

1 of 2 16/12/2009 23:21
Cancer genomes reveal risks of sun and smoke : Nature News http://www.nature.com/news/2009/091216/full/news.2009.1143.html

sequencing. Steve Elledge, an expert in DNA damage and cancer genetics at Harvard Medical
School in Boston, Massachusetts, was impressed with the new analysis but says that the
potential impact on cancer diagnosis and treatment will not be fully felt until scientists have
hundreds of sequences at hand — a costly prospect. "It's still very expensive, and I think all
these efforts should be coupled with an equal amount of effort on studying gene function," he
says.

References

1. Pleasance, E. D. et al. Nature advance online publication doi:10.1038/nature08629 (2009).

2. Pleasance, E. D. et al. Nature advance online publication doi:10.1038/nature08658 (2009).
3. Ley, T. J. et al. Nature 456, 66-72 (2008).
4. Shah, S. P. et al. Nature 461, 809-813 (2009).

Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report
this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before
comments are published.

There are currently no comments.

Add your own comment

You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Remember this is for feedback and
discussion - not for publishing papers, press releases or advertisements, for example. If you ramble on in an annoying way too often, we may remove your
posting privileges.

You need to be registered with Nature to leave a comment. Please log in or register as a new user. You will be re-directed back to this page.

Log in / register

Nature ISSN 0028-0836 EISSN 1476-4687

About NPG Privacy policy Nature News About Nature News

Contact NPG Legal notice Naturejobs Nature News Sitemap
RSS web feeds Accessibility statement Nature Asia
Help Nature Education
Search: go

© 2009 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, CrossRef and COUNTER

2 of 2 16/12/2009 23:21